Home » Pharma
Biocon and Pfizer Conclude Commercialization Agreement
Biocon and Pfizer today announced the conclusion of their alliance to commercialize Biocon’s biosimilar versions of Insulin and Insulin analog products. The companies have agreed that due to the individual priorities for their respective biosimilars businesses, it is in their best interest to move forward independently.
Biocon and Pfizer are committed to ensuring continuity of patient care and...
Praj Industries Limited Honored with Bio Excellence Award 2012
Praj Industries Limited has been bestowed the Bio Excellence Award 2012 in the BioIndustrial category at the Bangalore India Bio. The award was presented at the hands of Dr. T. Ramasamy, Secretary of the DBT. This award was given to Praj for the hard work and efforts of Praj Matrix- the innovation center towards research in bioindustrials. Praj was also awarded with Bio Excellence Award in the 2009.
Innovation...
Oxitec Secures GBP8 Million Investment to Continue Fight Against Dengue Fever
Oxitec Ltd, a British company pioneering a new approach to combating dengue fever, announced today that it has secured GBP8 million of new investment. The investment will finance further trials of the Oxitec Control Programme, designed to reduce populations of the dengue mosquito in communities hardest hit by the disease. The Oxitec solution harnesses advanced genetics to create ‘sterile’...
Panvo Organics moving ahead in the Pharma sector
A trading house company that started with trading of API only, had a vision to get bigger and better but the path chosen was slow and steady. In 2006, they turned into a private limited company and started sourcing pharmaceuticals. Two men, Nirmal Vora and Jawahar Pandian, shook hands and started developing resources to expand the company. Nirmal Vora, a chemical engineer by education and a management...
AEON formulations leading their way in to Pharma domain under their strong leadership
Every day, at sunrise, 63 years old Mr chatwal, takes his morning walk, followed by daily dose of medicine, recommended by his trusted doctors. He was a healthy man until one day when old age welcomed him when on a regular checkup; his doctor diagnosed him with osteoarthritis. Along with many other medicines, he also takes his daily dose of glucosamine. He feels better now, and thanks all the companies...
Asia Pacific Risk Management Services Pvt. Ltd the Enterprise providing Risk Management Services for Insurance,Pharma and various other industries
Asia Pacific Risk Management Services Pvt. Ltd., (APRMS), started in 2004, is into providing specialized services in the Risk Management for various industries and insurers and brokers. The expertise team consists of mechanical and chemical engineers with the skill-sets in safety and insurance requirement of a corporate and also understands the requirements of insurers and the reinsurers. They are...
Aveo Falls After Cancer Drug Data Miss Investor Expectations
Aveo Pharmaceuticals Inc., manufacturer of an experimental medicine for kidney cancer, fails to attract the investors for having “ultra high expectations” but still Aveo is planning to expand in preparation for approval of the medicine, called tivozanib.
The drug helps patients with advanced renal cell carcinoma live for 11.9 months without their disease progressing in a late-stage study, compared...
Supreet Deshpande -VLife’s CEO Receives BioSpectrumAsia Entrepreneur of the Year 2011 Award
The prestigious annual BioSpectrum Awards constituted in 2003 by BioSpectrumAsia – the voice of Biotech industry to recognize the exceptional contributions of individuals to the development of biotech sector in the country were announced for 2011. In a glittering ceremony on 16th December 2011 held at Hotel Sheraton in Bangaluru and attended by eminent personalities in Biotech Industry and Academia,...
Pharma-Big Giant J&J enters into agreement for anti-cancer drug
Janssen Biotech, one of the Janssen Pharmaceutical Companies has entered into an agreement with Johnson & Johnson in Pharmacyclics, a prominent area in the research domain who will jointly develop and market the anti-cancer compound, PCI-32765.
A number of phase I and II studies with PCI-32765 are ongoing across a panel of B-cell malignancy disorders, including chronic lymphocytic leukemia, mantle...
Prakruthik Health launches nano-tech based products ‘En-Tube’ capsules
Prakruthik Health Care (PHCPL), the first India Nano-technology based Preventive Health Care Company has launched its first product, En-Tube capsules, the best solution for intra-corporeal detoxification through nano-technology
En-Tube, indeed has been a well researched formulation of highly purified, Nano Svarijika, a mineral and Platago Ovata Husk, a herb. These ingredients are an Ayurvedic Composition...
RXMD Strategic execution group providing clinical development expertise to the biotech and pharmaceutical domain
RxMD Founded in 2000,is a strategic execution group providing clinical development expertise to the biotech and pharmaceutical community. Managed and operated by physician-scientists, RxMD has, over the years, played critical roles in drug development programs of leading global pharmaceutical companies. It has contributed to the development of several drug candidates and helped bring five drugs to...
Pharmaceutical research and testing Consultancy-Groupe Athena, Inc. Profits Soar on Record Revenues
Groupe Athena, Inc. (Pink sheets GATA.PK) announced today record revenues of $25,112,636 for the recent fiscal year ended June 30, 2011, more than doubling the revenues of the prior fiscal year. After tax earnings also more than doubled for the same period to $2,106,808 or $.045 per share.
The Company’s Chairman, D. Purohit stated, “Of course we are very pleased with our current revenue...
Lupin Launches Additional Strengths of Generic Lotrel Capsules
Lupin Pharmaceuticals, Inc. (LPI) announced today that the U.S. Food and Drug Administration (US FDA) has granted final approval for its Amlodipine / Benazepril 5mg/40mg, and 10mg/40mg capsules. Commercial shipments of the product have already commenced. This approval completes the product line as the Company was granted final approval for Amlodipine / Benazepril 2.5mg/10mg, 5mg/10mg, 5mg/20mg...
The Drugs Controller General India DCGI Suspends Approval of M/S Axis Clinicals Ltd Hyderabad
The Drugs Controller General (India)’s South Zone Office, Chennai and Sub-zonal office, Hyderabad has conducted investigations in the matter of recent reports about certain irregularities in conduct of clinical study by M/s Axis Clinicals Ltd., Hyderabad in violation of the norms specified in Schedule Y of the Drugs and Cosmetics Rules. The investigations have revealed various irregularities...
Jubilant and AstraZeneca Announce Successful Delivery of Early Milestones in Drug Discovery
Jubilant Biosys Ltd., Bengaluru, based subsidiary of Jubilant Life Sciences Ltd., and AstraZeneca, today announced another successful delivery of an early stage milestone in the Pain therapeutic area.
The collaboration, initiated two years ago in the Neuroscience therapeutic area, has now expanded to Cardiovascular and Metabolic diseases and focuses on the delivery of a steady stream of preclinical...
